India to Myanmar: Cefixime Export Trade Route

The India to Myanmar Cefixime corridor is one of India's established pharmaceutical export routes, with 383 shipments documented worth a combined $7.6M USD. The route is dominated by MAAN PHARMACEUTICALS LTD, which alone accounts for roughly 35% of all export value, reflecting the consolidated nature of India's cefixime manufacturing sector.

Across 90 active suppliers, the average shipment value stands at $19.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with cefixime's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 29.1%, placing it at rank #13 among India's top cefixime export destinations globally.

On the import side, key buyers of Indian cefixime in Myanmar include YAR PYE COMPANY LIMITED, READY MEDICINE CO LTD, KAUNG SU COMPANY LIMITED and 124 others. YAR PYE COMPANY LIMITED is the single largest importer with 4 shipments valued at $2.6M USD.

India's cefixime exports to Myanmar are driven primarily by a handful of large-scale manufacturers. MAAN PHARMACEUTICALS LTD with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 90 active exporters signals a competitive but concentrated market — buyers in Myanmar benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MAAN PHARMACEUTICALS LTD, INNOVA CAPTAB LIMITED, ARAVIS PHARMACEUTICALS — together account for 44% of total trade value on this route. The average shipment value of $19.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as k-cef 200(cefixime-200)(pack:10x10)(phar and axim-2 tablets cefixime trihydrate usp, suggesting that buyers in Myanmar tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, YAR PYE COMPANY LIMITED is the largest importer with 4 shipments worth $2.6M USD — representing 34% of all cefixime imports from India on this route. A total of 127 buyers are active on this corridor.